RecruitingNot ApplicableNCT03698149

ECoG BMI for Motor and Speech Control

A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control


Sponsor

Karunesh Ganguly

Enrollment

3 participants

Start Date

Nov 9, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a brain-computer interface — a device implanted in the brain — that reads electrical signals from the brain and translates them into movement or speech for people with serious paralysis or loss of limb function, with the goal of restoring independence. **You may be eligible if...** - You are over 21 years old - You have severely limited use of both arms due to stroke, ALS (Lou Gehrig's disease), multiple sclerosis, spinal cord injury, brainstem stroke, muscular dystrophy, or severe nerve disease - Your disability is severe (Modified Rankin Scale score of 4 or more) - At least 1 year has passed since your stroke or spinal cord injury - You live within a 2-hour drive of UCSF **You may NOT be eligible if...** - You are pregnant or breastfeeding - You cannot understand or read English - You have dementia - You have active severe depression, schizophrenia, bipolar disorder, OCD, or certain personality disorders - You have a history of suicide attempt - You have a history of substance abuse - You have cancer, uncontrolled high blood pressure, or major organ failure - You have had prior brain surgery or a history of seizures - You have an implanted electronic device (pacemaker, neurostimulator, etc.) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPMT/Blackrock Combination Device

PMT Subdural Cortical Electrodes/Blackrock NeuroPort Array and NeuroPort System


Locations(1)

University of California San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03698149


Related Trials